Ryman Healthcare Limited
RYHTY
$7.45
-$0.04-0.53%
| Weiss Ratings | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.64% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -11.31% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -19.11% | |||
| 52-Week Low % Change | 11.46% | |||
| Price | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.26 | |||
| 52-Week Low Price | $6.72 | |||
| 52-Week Low Price (Date) | Mar 25, 2025 | |||
| 52-Week High Price (Date) | Mar 05, 2025 | |||
| Valuation | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.58B | |||
| Enterprise Value | 3.06B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.08 | |||
| Earnings Per Share Growth | -132.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 11.58 | |||
| Price/Book (Q) | 1.88 | |||
| Enterprise Value/Revenue (TTM) | 6.97 | |||
| Price | $7.45 | |||
| Enterprise Value/EBITDA (TTM) | 200.39 | |||
| Enterprise Value/EBIT | -396.92 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 687.64M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.43 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.43 | |||
| Company Info | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 64 3 366 4069 | |||
| Address | -- | |||
| Website | www.rymanhealthcare.co.nz | |||
| Country | New Zealand | |||
| Year Founded | 1984 | |||
| Profitability | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.75% | |||
| Profit Margin | -11.97% | |||
| Management Effectiveness | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.06% | |||
| Return on Equity | -- | |||
| Income Statement | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 411.59M | |||
| Total Revenue (TTM) | 444.64M | |||
| Revenue Per Share | $0.65 | |||
| Gross Profit (TTM) | 18.36M | |||
| EBITDA (TTM) | 15.46M | |||
| EBIT (TTM) | -7.80M | |||
| Net Income (TTM) | -53.26M | |||
| Net Income Avl. to Common (TTM) | -53.26M | |||
| Total Revenue Growth (Q YOY) | 11.03% | |||
| Earnings Growth (Q YOY) | -49.02% | |||
| EPS Diluted (TTM) | -0.08 | |||
| EPS Diluted Growth (Q YOY) | -49.45% | |||
| Balance Sheet | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.37M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 163.62M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.74B | |||
| Current Ratio (Q) | 0.045 | |||
| Book Value Per Share (Q) | $3.99 | |||
| Total Assets (Q) | 8.16B | |||
| Total Current Liabilities (Q) | 3.64B | |||
| Total Debt (Q) | 1.68B | |||
| Total Liabilities (Q) | 5.42B | |||
| Total Common Equity (Q) | 2.74B | |||
| Cash Flow | RYHTY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -415.26M | |||
| Cash from Financing (TTM) | 41.74M | |||
| Net Change in Cash (TTM) | -6.52M | |||
| Levered Free Cash Flow (TTM) | 3.33B | |||
| Cash from Operations (TTM) | 366.99M | |||
